Prescription medicine
Iron dextran Brand names: Infed
Iron dextran (Infed) is a prescription medicine with an FDA approval on record since 1957. No generic is listed; pharmacies paid $18.89 per mL (Infed 100 mg/2 mL vial) in the October 7, 2026 NADAC survey.
- No generic listed
- Boxed warning
Check it at the source: the iron dextran FDA label on DailyMed (effective August 2, 2024, Allergan, Inc.); the NDA 10787 record on Drugs@FDA; every iron dextran label on DailyMed.
Highlights of the record
FDA label of August 2, 2024; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
RISK FOR ANAPHYLACTIC-TYPE REACTIONS.
Anaphylactic-type reactions, including fatalities, have been reported following the parenteral administration of iron dextran injection. Have resuscitation equipment and personnel trained in the detection and treatment of anaphylactic-type reactions readily available during INFeD administration. Administer a test INFeD dose prior to the first therapeutic dose. If no signs or symptoms of anaphylactic-type reactions follow the test dose, administer the full therapeutic INFeD dose. During all INFeD administrations, observe for signs or symptoms of anaphylactic-type reactions. Fatal reactions have been reported following the test dose of iron dextran injection. Fatal reactions have also occurred in situations where the test dose was tolerated. Use INFeD only in patients in whom clinical and laboratory investigations have established an iron deficient state not amenable to oral iron therapy. Patients with a history of drug allergy or multiple drug allergies may be at increased risk of anaphylactic-type reactions to INFeD. WARNING: RISK FOR ANAPHYLACTIC-TYPE REACTIONS See full prescribing information for complete boxed warning. Anaphylactic-type reactions, including fatalities, have been reported following the parenteral administration of iron dextran injection. […]
Used for
From the label: indications and usageINFeD is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response to oral iron.
Forms and strengths
- 50 mg/ml
Injection.
On the market
- Earliest approval on file
- April 25, 1957 Iron Dextran, Sanofi Aventis Us; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 3 of which 0 under generic applications, 3 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $18.89 per mL Infed 100 mg/2 mL vial
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 1,436 through July 30, 2026
What is iron dextran used for?
From the label: indications and usageINFeD is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or have had an unsatisfactory response to oral iron. INFeD, an iron replacement product, is indicated for treatment of adult and pediatric patients of age 4 months and older with documented iron deficiency who have intolerance to oral iron or an unsatisfactory response to oral iron.
FDA pharmacologic class: Parenteral Iron Replacement and Phosphate Binder.
Source: FDA drug label (INFeD), Allergan, Inc., effective August 2, 2024 (SPL set 94b01b1e-794b-4bea-8e24-2e54683fc023), via openFDA; the full label on DailyMed
Is there a generic for iron dextran (Infed)?
No generic iron dextran is approved (Drugs@FDA, October 8, 2026).
- 1957 earliest approval on file
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for iron dextran (Infed)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $18.89 per mL (Infed 100 mg/2 mL vial), up 5% from $18.02 on October 8, 2025. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Infed 100 mg/2 mL vial (brand)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Infed 100 mg/2 mL vial | Brand | $18.89 per mL | $37.78 per vial | +5% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What does the iron dextran label say about other medicines?
The iron dextran label names no other medicine on this site. The labels of 1 other medicine name iron dextran. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
Source: FDA drug label (INFeD), Allergan, Inc., effective August 2, 2024 (SPL set 94b01b1e-794b-4bea-8e24-2e54683fc023), via openFDA; the full label on DailyMed
What do FAERS reports show for iron dextran?
The FDA Adverse Event Reporting System holds 1,436 reports that list iron dextran among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 123 are coded as a death and 348 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Other parenteral iron replacements
- the pharmacologic class, with prices and generics
- Iron dextran side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other